Which US or EU regulatory record settles a medicine claim on a date. Keyless; not medical advice.
Maintain this server? Claim it
Call this server's tools from your browser. Nothing to install.
Requests go through mcptry because browsers can't call most MCP servers directly. Header values are sent to the server for that request only and are never stored or logged.
Tool list from our last check. Connect live to refresh it.
For one medicine, one market and one date: which source settles whether the medicine is registered (P1) or authorised for an indication (P2), what that source says about the claim where its content has been checked, where this market's label differs from the US and EU labels, and what is unresolved. Cite the pointer URL of the record the answer rests on. supported_attested means the authorisation holder's own approved label, read under the attestation conditions, states the claim; it never settles it. Where that label does not state the indication, or its content has not been checked, the answer is unresolved. An unresolved answer is unknown, never false.
The market: an ISO 3166-1 alpha-2 code (US, AE, SA, DE) or EU.
The brand or active substance name, exactly (for example Mounjaro or tirzepatide).
P1: registered or authorised in the market. P2: authorised for an indication.
The date the claim is about, YYYY-MM-DD. Defaults to today (UTC).
Required for P2: one indication from the published list. cv_risk_reduction_obesity: reducing the risk of major adverse cardiovascular events; mash_with_fibrosis: metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis; osa_with_obesity: obstructive sleep apnoea; t2dm_ckd_risk_reduction: reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death; t2dm_cv_risk_reduction: reducing the risk of major adverse cardiovascular events; t2dm_glycaemic_control: glycaemic control in type 2 diabetes; weight_management: weight management.
Optional for P2: the youngest age the claim says the indication covers.
Pick your client. Values in capitals, like YOUR_TOKEN, are yours to fill in.
Run in a terminal
claude mcp add --transport http reference https://alphacitation.com/api/v1/reference/mcp
For one medicine, one market and one date: which source settles whether the medicine is registered (P1) or authorised for an indication (P2), what that source says about the claim where its content has been checked, where this market's label differs from the US and EU labels, and what is unresolved. Cite the pointer URL of the record the answer rests on. supported_attested means the authorisation holder's own approved label, read under the attestation conditions, states the claim; it never settles it. Where that label does not state the indication, or its content has not been checked, the answer is unresolved. An unresolved answer is unknown, never false.
| Argument | Type | Description |
|---|---|---|
| date | string | The date the claim is about, YYYY-MM-DD. Defaults to today (UTC). |
| market* | string | The market: an ISO 3166-1 alpha-2 code (US, AE, SA, DE) or EU. |
| medicine* | string | The brand or active substance name, exactly (for example Mounjaro or tirzepatide). |
| indication | string | Required for P2: one indication from the published list. cv_risk_reduction_obesity: reducing the risk of major adverse cardiovascular events; mash_with_fibrosis: metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis; osa_with_obesity: obstructive sleep apnoea; t2dm_ckd_risk_reduction: reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death; t2dm_cv_risk_reduction: reducing the risk of major adverse cardiovascular events; t2dm_glycaemic_control: glycaemic control in type 2 diabetes; weight_management: weight management. |
| proposition* | string | P1: registered or authorised in the market. P2: authorised for an indication. |
| populationMinAgeYears | integer | Optional for P2: the youngest age the claim says the indication covers. |
{
"type": "object",
"required": [
"medicine",
"market",
"proposition"
],
"properties": {
"date": {
"type": "string",
"description": "The date the claim is about, YYYY-MM-DD. Defaults to today (UTC)."
},
"market": {
"type": "string",
"description": "The market: an ISO 3166-1 alpha-2 code (US, AE, SA, DE) or EU."
},
"medicine": {
"type": "string",
"description": "The brand or active substance name, exactly (for example Mounjaro or tirzepatide)."
},
"indication": {
"enum": [
"cv_risk_reduction_obesity",
"mash_with_fibrosis",
"osa_with_obesity",
"t2dm_ckd_risk_reduction",
"t2dm_cv_risk_reduction",
"t2dm_glycaemic_control",
"weight_management"
],
"type": "string",
"description": "Required for P2: one indication from the published list. cv_risk_reduction_obesity: reducing the risk of major adverse cardiovascular events; mash_with_fibrosis: metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis; osa_with_obesity: obstructive sleep apnoea; t2dm_ckd_risk_reduction: reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death; t2dm_cv_risk_reduction: reducing the risk of major adverse cardiovascular events; t2dm_glycaemic_control: glycaemic control in type 2 diabetes; weight_management: weight management."
},
"proposition": {
"enum": [
"P1",
"P2"
],
"type": "string",
"description": "P1: registered or authorised in the market. P2: authorised for an indication."
},
"populationMinAgeYears": {
"type": "integer",
"maximum": 120,
"minimum": 0,
"description": "Optional for P2: the youngest age the claim says the indication covers."
}
},
"additionalProperties": false
}For one ruling identifier (ACPREC-YYYY-NNNN): what was decided about an evidence conflict, why, on which records, its status now (settled, unresolved or superseded) and its RFC 3161 timestamp where one has been issued, together with a fresh lookup of the current governing record for the ruling's medicine, market and date where the ruling names one. A ruling is not evidence and decides no claim today: answer from the current record, and cite the ruling only for how the earlier conflict was decided. Where no current record is held, read the competent authority's own record.
| Argument | Type | Description |
|---|---|---|
| id* | string | The ruling identifier, for example ACPREC-2026-0001. |
| date | string | The date to resolve the current record for, YYYY-MM-DD. Defaults to today (UTC). |
{
"type": "object",
"required": [
"id"
],
"properties": {
"id": {
"type": "string",
"pattern": "^ACPREC-[0-9]{4}-[0-9]{4}$",
"description": "The ruling identifier, for example ACPREC-2026-0001."
},
"date": {
"type": "string",
"description": "The date to resolve the current record for, YYYY-MM-DD. Defaults to today (UTC)."
}
},
"additionalProperties": false
}We read every tool's name, description and inputs the way the model will, looking for instructions hidden from you. A clean result means no warning signs, not a guarantee. Scanned Nov 16, 2026.